Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

832 recalls, newest first

Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-9283-01 D-1621-2020
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0792-2021
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0791-2021
Class I · High risk

Red-E Tablet

Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.

Terminated Chemical / undeclared The Protein Shoppe D-1595-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3305-4 D-1619-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3308-4 D-1618-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3303-1 D-1617-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3302-1 D-1616-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3299-6 D-1615-2020
Class I · High risk

WP Thyroid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5550-4 D-1614-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5950-2 D-1613-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-6150-2 D-1612-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5850-2 D-1611-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-6050-2 D-1610-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5750-2 D-1609-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5650-2 D-1608-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5550-2 D-1607-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5450-4 D-1606-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3312-4 D-1605-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3310-4 D-1604-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3309-4 D-1603-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3308-4 D-1602-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3307-4 D-1601-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3305-4 D-1600-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3303-4 D-1599-2020

Recalls by year